LENZ Therapeutics, Inc. — Form 10-Q

LENZ amended its Outside Director Compensation Policy effective immediately prior to the 2026 Annual Meeting. The policy establishes cash retainers ($50,000 base annually, plus committee chair/member fees ranging $5,000–$30,000) and automatic annual equity awards of 22,100 stock options vesting over one year, with an aggregate annual cap of $750,000 per director ($1M in year of initial appointment). No material changes to compensation structure, counterparties, dollar amounts, or share counts relative to prior policy were disclosed in this exhibit.